Loading...

The Cannabist Company Holdings Inc.

CBST.NENEO
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.14
CA$0.02(20.83%)

The Cannabist Company Holdings Inc. (CBST.NE) Financial Performance & Income Statement Overview

Review The Cannabist Company Holdings Inc. (CBST.NE) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-10.29%
10.29%
Operating Income Growth
78.84%
78.84%
Net Income Growth
39.74%
39.74%
Operating Cash Flow Growth
-412.93%
412.93%
Operating Margin
-4.65%
4.65%
Gross Margin
35.03%
35.03%
Net Profit Margin
-24.32%
24.32%
ROE
1010.60%
1010.60%
ROIC
-4.68%
4.68%

The Cannabist Company Holdings Inc. (CBST.NE) Income Statement & Financial Overview

View the income breakdown for The Cannabist Company Holdings Inc. CBST.NE across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$87.44M$96.14M$114.78M$125.19M
Cost of Revenue$58.16M$62.24M$70.97M$77.14M
Gross Profit$29.29M$33.90M$43.81M$41.36M
Gross Profit Ratio$0.33$0.35$0.38$0.33
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$32.52M$40.59M$43.30M$33.36M
Operating Expenses$37.44M$47.81M$49.44M$40.05M
Total Costs & Expenses$95.60M$110.05M$120.41M$117.18M
Interest Income$441000.00$2.17M$338000.00$132000.00
Interest Expense$9.32M$12.44M$9.95M$10.61M
Depreciation & Amortization$8.65M$9.66M$11.77M$13.58M
EBITDA-$13.45M-$31.35M$41.80M$20.19M
EBITDA Ratio-$0.15-$0.33$0.36$0.16
Operating Income-$8.16M-$13.92M-$5.63M$8.006M
Operating Income Ratio-$0.09-$0.14-$0.05$0.06
Other Income/Expenses (Net)-$23.25M-$38.28M$25.70M-$12.007M
Income Before Tax-$31.41M-$52.19M$20.07M-$4.001M
Income Before Tax Ratio-$0.36-$0.54$0.17-$0.03
Income Tax Expense$794000.00$2.96M$21.84M$9.64M
Net Income-$32.20M-$54.61M-$1.86M-$14.34M
Net Income Ratio-$0.37-$0.57-$0.02-$0.11
EPS-$0.07-$0.12-$0.004-$0.03
Diluted EPS-$0.07-$0.12-$0.004-$0.03
Weighted Avg Shares Outstanding$473.01M$462.50M$470.55M$460.65M
Weighted Avg Shares Outstanding (Diluted)$473.01M$462.50M$470.55M$460.65M

Over the last four quarters, The Cannabist Company Holdings Inc.'s revenue moved from $125.19M in Q2 2024 to $87.44M in Q1 2025. Operating income in Q1 2025 was -$8.16M, with a strong operating margin of -9%. Despite fluctuations in R&D and SG&A expenses, EBITDA for The Cannabist Company Holdings Inc. remained robust at -$13.45M, reflecting operational efficiency. Net income rose to -$32.20M, with an EPS of -$0.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;